Skip to main content
Veterinary Medicines

QUINOCILIN SUSPENSION INYECTABLE

Authorised
  • Ampicillin trihydrate
  • COLISTIN SULFATE

Product identification

Medicine name:
QUINOCILIN SUSPENSION INYECTABLE
Active substance:
  • Ampicillin trihydrate
  • COLISTIN SULFATE
Target species:
  • Sheep
  • Pig
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Ampicillin trihydrate
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • COLISTIN SULFATE
    250000.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Sheep
      • Meat and offal
        22
        day
      • Milk
        no withdrawal period
    • Pig
      • Meat and offal
        22
        day
  • Subcutaneous use
    • Sheep
      • Meat and offal
        22
        day
      • Milk
        no withdrawal period
    • Pig
      • Meat and offal
        22
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RA01
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Maymo S.A.U.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Maymo S.A.
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 2630 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/04/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/04/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/04/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."